OBIO
Orchestra BioMed Holdings Inc.
NASDAQ: OBIO · HEALTHCARE · BIOTECHNOLOGY
$3.80
-2.56% today
Updated 2026-04-29
Market cap
$239.94M
P/E ratio
—
P/S ratio
7.17x
EPS (TTM)
$-1.11
Dividend yield
—
52W range
$2 – $5
Volume
0.2M
Orchestra BioMed Holdings Inc. (OBIO) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+41.6%
Last 4 quarters
Revenue YoY growth
+12120.2%
Most recent quarter
EPS YoY growth
+161.9%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.5%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-8.7%
2026-03-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-12 | $0.26 | +168.7% | $4.60 | $4.20 | -8.7% |
| 2025-11-10 | $-0.40 | +13.0% | $3.81 | $4.10 | +7.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.38 | $0.26 | +168.7% | $30.92M | +12120.2% |
| 2025-09-30 | $-0.46 | $-0.40 | +13.0% | $861000.00 | -12.8% |
| 2025-06-30 | $-0.46 | $-0.50 | -8.7% | $836000.00 | +7.5% |
| 2025-03-31 | $-0.46 | $-0.49 | -6.5% | $868000.00 | +40.0% |
| 2024-12-31 | $-0.45 | $-0.42 | +6.7% | $253000.00 | -3.4% |
| 2024-09-30 | $-0.44 | $-0.41 | +7.3% | $987000.00 | +135.6% |
| 2024-06-30 | $-0.40 | $-0.45 | -12.5% | $778000.00 | -15.0% |
| 2024-03-31 | $-0.40 | $-0.38 | +5.0% | $620000.00 | -46.7% |
| 2023-12-31 | $-0.38 | $-0.37 | +2.6% | $262000.00 | — |
| 2023-09-30 | $-0.39 | $-0.38 | +2.6% | $419000.00 | — |
| 2023-06-30 | $-0.41 | $-0.35 | +14.6% | $915000.00 | — |
| 2023-03-31 | $-0.28 | $-0.40 | -42.9% | $1.16M | — |
Frequently asked questions
Has Orchestra BioMed Holdings Inc. beaten earnings estimates?
Orchestra BioMed Holdings Inc. has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +41.6% over the last 4 quarters.
How does OBIO stock react to earnings?
OBIO stock has moved an average of -0.5% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Orchestra BioMed Holdings Inc.'s revenue growth rate?
Orchestra BioMed Holdings Inc. reported year-over-year revenue growth of +12120.2% in its most recent quarter, with EPS growing +161.9% year-over-year.